Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel amide-mediated route for Bempedoic Acid reduces steps and improves purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN111548325A details a novel synthesis of 7-chloro-benzothiazepine-1,1-dioxide, offering improved yield and halogen introduction for reliable pharmaceutical intermediate supply chains.
Patent CN104926674B details a novel route for Z-unsaturated amides offering safer processing and reduced waste for global pharmaceutical intermediate supply chains.
Patent CN117843613A reveals high-yield synthesis for dabigatran intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel aqueous synthesis of diazinium derivatives using phosphotungstic acid. Offers high yield, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN102040614A reveals a water-phase method for Cephalothin Acid, reducing solvent use by over 70% and enhancing safety for API manufacturing supply chains.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113548971A reveals a novel reductive amination route for spermidine. This process offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN103641879A details a novel chemical route for prednisolone intermediates using plant sterols, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel patent CN104193689A offers cost-effective Erlotinib synthesis. Avoids palladium catalysts. Ensures supply chain stability for pharmaceutical intermediates.
Novel patent CN118146139A offers mild conditions for 4-amino-1-methylpiperidine. Reduces cost and supply risk for pharma intermediates manufacturing.
Novel catalytic route for cis-bicyclo [3.1.0] hex-3-ol reduces cost and improves safety for pharmaceutical intermediates manufacturing supply chains.
Novel Pd-catalyzed route for cis-fused beta-lactam compounds. Enhances supply chain reliability and reduces manufacturing costs for antibiotic intermediates.
Novel silver triflate method improves yield and stability for high-purity pharmaceutical intermediates supply chain optimization.
Novel Leuckart reaction route improves yield and purity for Alzheimer's drug intermediates, offering cost-effective manufacturing solutions.
Patent CN106278965B details a copper-catalyzed method for aryl-alkyl asymmetric persulfides. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Patent CN102875444A details a Cu-catalyzed route for oxindoles. Offers high purity, mild conditions, and scalable manufacturing for pharma intermediates.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.